Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 163, Issue 1, 2012, Pages 51-58

  Sheng, Bo ^a   Liu, Jin ^a   Li, Guo Hua ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

AMP activated protein kinase (AMPK); Daphnia pulex; Hypoxia inducible factor (HIF); Mammalian target of rapamycin (mTOR); Metformin

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN;

ARTICLE; CELL ENERGY; CONCENTRATION RESPONSE; DAPHNIA PULEX; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENE TARGETING; HYPOXIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALIA; DAPHNIA PULEX; INVERTEBRATA; MAMMALIA; RAPTORES;

EID: 84863003203     PISSN: 10964959     EISSN: 18791107     Source Type: Journal    
DOI: 10.1016/j.cbpb.2012.04.009     Document Type: Article

References (27)

1. Bailey C.J., Turner R.C. Metformin. N. Engl. J. Med. 1996, 334:574-579. [PubMed: 8569826].
2. Borger D.R., Gavrilescu L.C., Bucur M.C., Ivan M., Decaprio J.A. AMP-activated protein kinase is essential for survival in chronic hypoxia. Biochem. Biophys. Res. Commun. 2008, 370:230-234. [PubMed: 18359290].
3. Colbourne J.K., Pfrender M.E., Gilbert D., Thomas W.K., Tucker A., Oakley T.H., Tokishita S., Aerts A., Arnold G.J., Basu M.K., et al. The ecoresponsive genome of Daphnia pulex. Science 2011, 331:555-561. [PubMed: 21292972].
4. Dirnagl U., Becker K., Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009, 8:398-412. [PubMed: 19296922].
5. Dowling R.J., Zakikhani M., Fantus I.G., Pollak M., Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007, 67:10804-10812. [PubMed: 18006825].
6. Eckle T., Köhler D., Lehmann R., El Kasmi K., Eltzschig H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008, 118:166-175. [PubMed: 18591435].
7. Fong G.H., Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008, 15:635-641. [PubMed: 18259202].
8. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448. [PubMed: 16715053].
9. Gorr T.A., Gassmann M., Wappner P. Sensing and responding to hypoxia via HIF in model invertebrates. J. Insect Physiol. 2006, 52:349-364. [PubMed: 16500673].
10. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell. 2008, 30:14-226. [PubMed: 18439900].
11. Hardie D.G. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008, 582:81-89. [PubMed: 18022388].
12. Hudson C.C., Liu M., Chiang G.G., Otterness D.M., Loomis D.C., Kaper F., Giaccia A.J., Abraham R.T. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 2002, 22:7004-7014. [PubMed: 12242281].
13. Kalender A., Selvaraj A., Kim S.Y., Gulati P., Brûlé S., Viollet B., Kemp B.E., Bardeesy N., Dennis P., Schlager J.J., et al. Metformin, independent of AMPK, inhibits mTORC1 in a Rag GTPase-dependent manner. Cell Metab. 2010, 11:390-401. [PubMed: 20444419].
14. Kwiatkowski D.J., Manning B.D. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 2005, 14:R251-R258. [PubMed: 16244323].
15. Land S.C., Tee A.R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem. 2007, 282:20534-20543. [PubMed: 17502379].
16. LaRue B.L., Padilla P.A. Environmental and genetic preconditioning for long-term anoxia responses requires AMPK in Caenorhabditis elegans. PLoS One 2011, 6:e16790. [PubMed: 21304820].
17. Lee M., Hwang J.T., Lee H.J., Jung S.N., Kang I., Chi S.G., Kim S.S., Ha J. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem. 2003, 278:39653-39661. [PubMed: 12900407].
18. Livak K.L., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408. [PubMed:].
19. Nakayama K. Cellular signal transduction of the hypoxia response. J. Biochem. 2009, 146:757-765. [PubMed: 11846609].
20. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386. [PubMed: 10547847].
21. Rutter G.A., Da Silva Xavier G., Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 2003, 375:1-16. [PubMed: 12839490].
22. Semenza G.L. HIF-1: mediator of physiological and pathophysiological response to hypoxia. J. Appl. Physiol. 2000, 88:1474-1480. [PubMed: 10749844].
23. Sengupta S., Peterson T.R., Sabatini D.M. Regulation of the mTOR Complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell. 2010, 40:310-322. [PubMed: 20965424].
24. Vigneron F., Dos Santos P., Lemoine S., Bonnet M., Tariosse L., Couffinhal T., Duplaà C., Jaspard-Vinassa B. GSK-3β at the crossroads in the signaling of heart preconditioning: implication of mTOR and Wnt pathways. Cardiovasc. Res. 2011, 90:49-56. [PubMed: 21233250].
25. Weidemann A., Johnson R.S. Biology of HIF-1a. Cell Death Differ. 2008, 15:621-627. [PubMed: 18259201].
26. Wouters B.G., Koritzinsky M. Hypoxia signaling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8:851-864. [PubMed: 18846101].
27. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174. [PubMed: 11602624].